Sabine Atzor is Head of EU Regulatory Policy at F. Hoffmann-La Roche Ltd since 2010 and in her function she is Vice-chair of EFPIA's Regulatory Strategy Committee (RSC). She has contributed and provided leadership in numerous discussions within Roche and EFPIA, e.g. EU Clinical Trial Regulation, adaptive pathways, incentives, real world data and most recently on the EU Pharmaceutical Strategy and the revision of the EU Pharma Legislation. To support the industry association work, she was seconded to EFPIA from 2015-2016. Prior to joining Roche she worked for about 14 years in the public sector, of which almost 6 years in the Pharmaceuticals Unit of the European Commission, DG ENTR and later at DG SANCO. In this function, her focus was on the preparation of the Falsified Medicines Directive, management of the Influenza Pandemic in 2009, and agreements with third countries on GMP. Her earlier roles included head of the coordination unit for drugs for the German Länder at ZLG tasked with the setup of this unit and head of unit on pharmaceuticals and blood products at the regional Ministry of Health in Hesse.